Its inclusion in the ALS diagnostic routine should be contemplated, as it has the potential to enhance specificity, complementing the determination of NF-L levels, which demonstrates high sensitivity but lacks specificity. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.